Conexeu Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023
Net Income	-7.2	-3.92	-0.47	-0.04
Depreciation & Amortization	0.03	0.02	-	-
Stock-Based Compensation	0.62	2.18	0.01	0
Other Adjustments	0	-0.04	-0.18	-
Changes in Accounts Payable	0.25	0.09	0.45	0.03
Changes in Accrued Expenses	-	0.08	-	-
Changes in Income Taxes Payable	0.01	-0	-	-
Changes in Other Operating Activities	0.05	-0.06	-0.03	-
Operating Cash Flow	-4.35	-1.67	-0.23	-0
Capital Expenditures	-0.04	-0.02	-	-
Other Investing Activities	-	-0.07	-	-
Investing Cash Flow	-0.11	-0.09	-	-
Long-Term Debt Repaid	0	-0.09	-	-
Net Long-Term Debt Issued (Repaid)	0	-0.09	-	-
Issuance of Common Stock	10.82	6.42	0.53	0
Net Common Stock Issued (Repurchased)	10.82	6.42	0.53	0
Other Financing Activities	-	-0.05	0	0
Financing Cash Flow	11.68	6.28	0.53	0
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-0	0.01	-
Net Cash Flow	7.23	4.52	0.31	0
Free Cash Flow	-4.38	-1.69	-0.23	-0
Free Cash Flow Per Share	-0.24	-0.13	-0.03	-0.00
Levered Free Cash Flow	-6.88	-3.92	-0.05	-0
Unlevered Free Cash Flow	-6.97	-3.87	-0.22	-0

SEC Filings: 10-K · 10-Q